Japan's Eisai to buy US MGI Pharma for $3.9 bln Reuters

USA The planned
purchase of the cancer specialist is the latest example of accelerating M&A
in the biotechnology sector, which has seen a scramble by drugmakers ...

http://www.reuters.com/article/health-SP/idUSTKV00291420071210

See all stories on this topic:
http://news.google.com/news?hl=en&ncl=http://www.reuters.com/article/health
-SP/idUSTKV00291420071210


Biotech News
AZhttp, Inc.
Biotechnology Marketing